Genetic basis of I-complex plasmid stability and conjugation

PLoS Genet. 2023 Jun 22;19(6):e1010773. doi: 10.1371/journal.pgen.1010773. eCollection 2023 Jun.

Abstract

Plasmids are major drivers of increasing antibiotic resistance, necessitating an urgent need to understand their biology. Here we describe a detailed dissection of the molecular components controlling the genetics of I-complex plasmids, a group of antibiotic resistance plasmids found frequently in pathogenic Escherichia coli and other Enterobacteriaceae that cause significant human disease. We show these plasmids cluster into four distinct subgroups, with the prototype IncI1 plasmid R64 subgroup displaying low nucleotide sequence conservation to other I-complex plasmids. Using pMS7163B, an I-complex plasmid distantly related to R64, we performed a high-resolution transposon-based genetic screen and defined genes involved in replication, stability, and conjugative transfer. We identified the replicon and a partitioning system as essential for replication/stability. Genes required for conjugation included the type IV secretion system, relaxosome, and several uncharacterised genes located in the pMS7163B leading transfer region that exhibited an upstream strand-specific transposon insertion bias. The overexpression of these genes severely impacted host cell growth or reduced fitness during mixed competitive growth, demonstrating that their expression must be controlled to avoid deleterious impacts. These genes were present in >80% of all I-complex plasmids and broadly conserved across multiple plasmid incompatibility groups, implicating an important role in plasmid dissemination.

MeSH terms

  • Base Sequence
  • Conjugation, Genetic
  • Enterobacteriaceae / genetics
  • Escherichia coli Proteins* / genetics
  • Escherichia coli* / genetics
  • Humans
  • Plasmids / genetics

Substances

  • Escherichia coli Proteins

Grants and funding

This work was supported by grants from the Australian National Health and Medical Research Council (APP1181958 and APP2001431 to MAS, M-DP, NTKN) and the Australian Medical Research Future Fund (APP1152503 to DLP, MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.